382 related articles for article (PubMed ID: 1920939)
1. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
Kohara N
Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
[TBL] [Abstract][Full Text] [Related]
4. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between bone mineral density and secondary hyperparathyroidism bone disease].
Ning JP; Sun M; Toru I; Etsuo Y
Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):77-9. PubMed ID: 12212259
[TBL] [Abstract][Full Text] [Related]
6. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
7. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.
Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K
Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370
[TBL] [Abstract][Full Text] [Related]
8. [Research on the treatment of secondary hyperparathyroidism as a complication of chronic renal failure].
Sugimura T
Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1119-34. PubMed ID: 1808363
[TBL] [Abstract][Full Text] [Related]
9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
10. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
11. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
Motz W
Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
Williams ME
Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between weight, body composition and bone mass in peritoneal dialysis].
Negri AL; Barone R; Bogado CE; Zanchetta JR
Nefrologia; 2005; 25(3):269-74. PubMed ID: 16053008
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the bone mineral density in hemodialysis patients for different terms].
Tao L; Xu H; Sun M; Ikeda T
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):177-8. PubMed ID: 11938784
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.
Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N
Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534
[TBL] [Abstract][Full Text] [Related]
18. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
[TBL] [Abstract][Full Text] [Related]
20. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
